{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:50:18Z","timestamp":1792788618864,"version":"4.5.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-022-01020-9","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T08:02:46Z","timestamp":1664265766000},"page":"243-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["New Emerging Biomarkers for Bone Disease: Sclerostin and Dickkopf-1 (DKK1)"],"prefix":"10.1007","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5847-0556","authenticated-orcid":false,"given":"Aylin Sepinci","family":"Dincel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9624-5210","authenticated-orcid":false,"given":"Niklas Rye","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the IOF-IFCC Joint Committee on Bone Metabolism (C-BM)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"issue":"3","key":"1020_CR1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s00774-019-01057-1","volume":"38","author":"J Takada","year":"2020","unstructured":"Takada J et al (2020) Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial. J Bone Miner Metab 38(3):310\u2013315","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"1020_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13018-019-1100-6","volume":"14","author":"A Tian","year":"2019","unstructured":"Tian A et al (2019) Reference markers of bone turnover for prediction of fracture: a meta-analysis. J Orthop Surg Res 14(1):68","journal-title":"J Orthop Surg Res"},{"issue":"11","key":"1020_CR3","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1101\/gad.1424006","volume":"20","author":"K Willert","year":"2006","unstructured":"Willert K, Jones KA (2006) Wnt signaling: is the party in the nucleus? Genes Dev 20(11):1394\u20131404","journal-title":"Genes Dev"},{"issue":"19","key":"1020_CR4","doi-asserted-by":"publisher","first-page":"10840","DOI":"10.3390\/ijms221910840","volume":"22","author":"J Lojk","year":"2021","unstructured":"Lojk J, Marc J (2021) Roles of non-canonical wnt signalling pathways in bone biology. Int J Mol Sci 22(19):10840","journal-title":"Int J Mol Sci"},{"key":"1020_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.115076","volume":"130","author":"M Mulati","year":"2020","unstructured":"Mulati M et al (2020) The long noncoding RNA Crnde regulates osteoblast proliferation through the Wnt\/beta-catenin signaling pathway in mice. Bone 130:115076","journal-title":"Bone"},{"key":"1020_CR6","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.56434","author":"A Geng","year":"2020","unstructured":"Geng A et al (2020) A novel function of R-spondin1 in regulating estrogen receptor expression independent of Wnt\/beta-catenin signaling. Elife. https:\/\/doi.org\/10.7554\/eLife.56434","journal-title":"Elife"},{"issue":"6","key":"1020_CR7","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R (2012) Wnt\/beta-catenin signaling and disease. Cell 149(6):1192\u20131205","journal-title":"Cell"},{"issue":"1","key":"1020_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13287-021-02239-3","volume":"12","author":"M Chen","year":"2021","unstructured":"Chen M et al (2021) Morusin induces osteogenic differentiation of bone marrow mesenchymal stem cells by canonical Wnt\/beta-catenin pathway and prevents bone loss in an ovariectomized rat model. Stem Cell Res Ther 12(1):173","journal-title":"Stem Cell Res Ther"},{"key":"1020_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.22203\/eCM.v024a04","volume":"24","author":"C Galli","year":"2012","unstructured":"Galli C et al (2012) The importance of WNT pathways for bone metabolism and their regulation by implant topography. Eur Cell Mater 24:46\u201359","journal-title":"Eur Cell Mater"},{"issue":"1","key":"1020_CR10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12891-021-04365-8","volume":"22","author":"J Peng","year":"2021","unstructured":"Peng J et al (2021) Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis. BMC Musculoskelet Disord 22(1):480","journal-title":"BMC Musculoskelet Disord"},{"key":"1020_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev-physiol-021119-034332","volume":"82","author":"AG Robling","year":"2020","unstructured":"Robling AG, Bonewald LF (2020) The osteocyte: new insights. Annu Rev Physiol 82:485\u2013506","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"1020_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1101\/gad.855501","volume":"15","author":"MJ Marvin","year":"2001","unstructured":"Marvin MJ et al (2001) Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes Dev 15(3):316\u2013327","journal-title":"Genes Dev"},{"issue":"1","key":"1020_CR13","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1038\/s41467-020-19155-4","volume":"11","author":"J Kim","year":"2020","unstructured":"Kim J et al (2020) Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains. Nat Commun 11(1):5357","journal-title":"Nat Commun"},{"issue":"2","key":"1020_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/bbrc.1999.1860","volume":"268","author":"A Kikuchi","year":"2000","unstructured":"Kikuchi A (2000) Regulation of beta-catenin signaling in the Wnt pathway. Biochem Biophys Res Commun 268(2):243\u2013248","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1020_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bbrc.2006.06.082","volume":"347","author":"DK Lee","year":"2006","unstructured":"Lee DK et al (2006) Activation of the canonical Wnt\/beta-catenin pathway enhances monocyte adhesion to endothelial cells. Biochem Biophys Res Commun 347(1):109\u2013116","journal-title":"Biochem Biophys Res Commun"},{"key":"1020_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.biomaterials.2015.07.021","volume":"67","author":"J Salbach-Hirsch","year":"2015","unstructured":"Salbach-Hirsch J et al (2015) Structural and functional insights into sclerostin-glycosaminoglycan interactions in bone. Biomaterials 67:335\u2013345","journal-title":"Biomaterials"},{"issue":"24","key":"1020_CR17","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1002\/cmdc.201700551","volume":"12","author":"S Brogi","year":"2017","unstructured":"Brogi S et al (2017) Activation of the Wnt pathway by small peptides: rational design synthesis and biological evaluation. Chem Med Chem 12(24):2074\u20132085","journal-title":"Chem Med Chem"},{"issue":"57","key":"1020_CR18","doi-asserted-by":"publisher","first-page":"7469","DOI":"10.1038\/sj.onc.1210054","volume":"25","author":"C Niehrs","year":"2006","unstructured":"Niehrs C (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25(57):7469\u20137481","journal-title":"Oncogene"},{"issue":"5","key":"1020_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.devcel.2011.09.003","volume":"21","author":"VE Ahn","year":"2011","unstructured":"Ahn VE et al (2011) Structural basis of Wnt signaling inhibition by Dickkopf binding to LRP5\/6. Dev Cell 21(5):862\u2013873","journal-title":"Dev Cell"},{"issue":"1","key":"1020_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1134\/S0026893317010095","volume":"51","author":"S Khalili","year":"2017","unstructured":"Khalili S, Rasaee MJ, Bamdad T (2017) 3D structure of DKK1 indicates its involvement in both canonical and non-canonical Wnt pathways. Mol Biol (Mosk) 51(1):180\u2013192","journal-title":"Mol Biol (Mosk)"},{"issue":"9","key":"1020_CR21","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1074\/jbc.M705092200","volume":"283","author":"AG Robling","year":"2008","unstructured":"Robling AG et al (2008) Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost\/sclerostin. J Biol Chem 283(9):5866\u20135875","journal-title":"J Biol Chem"},{"issue":"5","key":"1020_CR22","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1172\/JCI28551","volume":"116","author":"V Krishnan","year":"2006","unstructured":"Krishnan V, Bryant HU, Macdougald OA (2006) Regulation of bone mass by Wnt signaling. J Clin Invest 116(5):1202\u20131209","journal-title":"J Clin Invest"},{"issue":"16","key":"1020_CR23","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F et al (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375(16):1532\u20131543","journal-title":"N Engl J Med"},{"issue":"10","key":"1020_CR24","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1093\/rheumatology\/kev410","volume":"55","author":"RD Chapurlat","year":"2016","unstructured":"Chapurlat RD, Confavreux CB (2016) Novel biological markers of bone: from bone metabolism to bone physiology. Rheumatology (Oxford) 55(10):1714\u20131725","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"1020_CR25","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s00198-016-3561-3","volume":"27","author":"E Cavalier","year":"2016","unstructured":"Cavalier E et al (2016) The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club. Osteoporos Int 27(7):2181\u20132195","journal-title":"Osteoporos Int"},{"key":"1020_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bone.2016.11.024","volume":"96","author":"MM Weivoda","year":"2017","unstructured":"Weivoda MM, Youssef SJ, Oursler MJ (2017) Sclerostin expression and functions beyond the osteocyte. Bone 96:45\u201350","journal-title":"Bone"},{"issue":"2","key":"1020_CR27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3390\/ijms22020489","volume":"22","author":"N Martinez-Gil","year":"2021","unstructured":"Martinez-Gil N et al (2021) Genetics and genomics of SOST: functional analysis of variants and genomic regulation in osteoblasts. Int J Mol Sci 22(2):489","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1020_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/sji.12392","volume":"83","author":"G Almroth","year":"2016","unstructured":"Almroth G et al (2016) Sclerostin, TNF-alpha and Interleukin-18 Correlate and are together with klotho related to other growth factors and cytokines in haemodialysis patients. Scand J Immunol 83(1):58\u201363","journal-title":"Scand J Immunol"},{"issue":"7","key":"1020_CR29","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1096\/fj.201601280R","volume":"31","author":"V Deepak","year":"2017","unstructured":"Deepak V, Kayastha P, McNamara LM (2017) Estrogen deficiency attenuates fluid flow-induced [Ca(2+)]i oscillations and mechanoresponsiveness of MLO-Y4 osteocytes. FASEB J 31(7):3027\u20133039","journal-title":"FASEB J"},{"issue":"13","key":"1020_CR30","doi-asserted-by":"publisher","first-page":"9035","DOI":"10.1074\/jbc.M112.405456","volume":"288","author":"GL Galea","year":"2013","unstructured":"Galea GL et al (2013) Estrogen receptor alpha mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor beta. J Biol Chem 288(13):9035\u20139048","journal-title":"J Biol Chem"},{"issue":"11","key":"1020_CR31","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1128\/MCB.24.11.4677-4684.2004","volume":"24","author":"Y Zhang","year":"2004","unstructured":"Zhang Y et al (2004) The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd. Mol Cell Biol 24(11):4677\u20134684","journal-title":"Mol Cell Biol"},{"issue":"8","key":"1020_CR32","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/ndt\/gfx282","volume":"33","author":"P Delanaye","year":"2018","unstructured":"Delanaye P et al (2018) Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know. Nephrol Dial Transplant 33(8):1404\u20131410","journal-title":"Nephrol Dial Transplant"},{"key":"1020_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12018-011-9123-5","volume":"10","author":"A van Lierop","year":"2012","unstructured":"van Lierop A et al (2012) The role of sclerostin in the pathophysiology of sclerosing bone dysplasias. Clinical Reviews in Bone and Mineral Metabolism 10:108\u2013116","journal-title":"Clinical Reviews in Bone and Mineral Metabolism"},{"issue":"7","key":"1020_CR34","doi-asserted-by":"publisher","first-page":"E1159","DOI":"10.1210\/jc.2011-0254","volume":"96","author":"M McNulty","year":"2011","unstructured":"McNulty M et al (2011) Determination of serum and plasma sclerostin concentrations by enzyme-linked immunoassays. J Clin Endocrinol Metab 96(7):E1159\u2013E1162","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1020_CR35","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s00223-015-0105-3","volume":"98","author":"I Piec","year":"2016","unstructured":"Piec I et al (2016) How accurate is your sclerostin measurement? Comparison between three commercially available sclerostin ELISA kits. Calcif Tissue Int 98(6):546\u2013555","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"1020_CR36","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00198-014-2635-3","volume":"25","author":"AG Costa","year":"2014","unstructured":"Costa AG et al (2014) Comparison of two commercially available ELISAs for circulating sclerostin. Osteoporos Int 25(5):1547\u20131554","journal-title":"Osteoporos Int"},{"issue":"1\u20132","key":"1020_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00508-021-01815-0","volume":"134","author":"K Kerschan-Schindl","year":"2022","unstructured":"Kerschan-Schindl K et al (2022) Circulating bioactive sclerostin levels in an Austrian population-based cohort. Wien Klin Wochenschr 134(1\u20132):39\u201344","journal-title":"Wien Klin Wochenschr"},{"key":"1020_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.bone.2018.03.013","volume":"111","author":"MT Drake","year":"2018","unstructured":"Drake MT et al (2018) Validation of a novel, rapid, high precision sclerostin assay not confounded by sclerostin fragments. Bone 111:36\u201343","journal-title":"Bone"},{"issue":"12","key":"1020_CR39","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.3390\/jcm8122027","volume":"8","author":"A Mare","year":"2019","unstructured":"Mare A et al (2019) Clinical inference of serum and bone sclerostin levels in patients with end-stage kidney disease. J Clin Med 8(12):2027","journal-title":"J Clin Med"},{"issue":"3","key":"1020_CR40","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00198-013-2486-3","volume":"25","author":"AL Kuipers","year":"2014","unstructured":"Kuipers AL et al (2014) Association of volumetric bone mineral density with abdominal aortic calcification in African ancestry men. Osteoporos Int 25(3):1063\u20131069","journal-title":"Osteoporos Int"},{"issue":"2","key":"1020_CR41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jbmr.217","volume":"26","author":"UI Modder","year":"2011","unstructured":"Modder UI et al (2011) Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res 26(2):373\u2013379","journal-title":"J Bone Miner Res"},{"issue":"12","key":"1020_CR42","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1210\/jc.2013-2106","volume":"98","author":"AG Costa","year":"2013","unstructured":"Costa AG et al (2013) Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women. J Clin Endocrinol Metab 98(12):4736\u20134743","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1020_CR43","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1002\/jbmr.479","volume":"26","author":"MS Ardawi","year":"2011","unstructured":"Ardawi MS et al (2011) Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res 26(12):2812\u20132822","journal-title":"J Bone Miner Res"},{"issue":"3","key":"1020_CR44","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00198-011-1669-z","volume":"23","author":"S Kirmani","year":"2012","unstructured":"Kirmani S et al (2012) Sclerostin levels during growth in children. Osteoporos Int 23(3):1123\u20131130","journal-title":"Osteoporos Int"},{"issue":"Pt 6","key":"1020_CR45","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1258\/acb.2012.011274","volume":"49","author":"DC Fischer","year":"2012","unstructured":"Fischer DC et al (2012) Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase. Ann Clin Biochem 49(Pt 6):546\u2013553","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"1020_CR46","doi-asserted-by":"publisher","first-page":"E149","DOI":"10.1210\/jc.2013-3148","volume":"99","author":"B Dawson-Hughes","year":"2014","unstructured":"Dawson-Hughes B et al (2014) Serum sclerostin levels vary with season. J Clin Endocrinol Metab 99(1):E149\u2013E152","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1020_CR47","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jocd.2021.07.008","volume":"25","author":"P Sharma-Ghimire","year":"2022","unstructured":"Sharma-Ghimire P et al (2022) Sclerostin and Dickkopf-1 characteristics according to age and physical activity levels in premenopausal women. J Clin Densitom 25(2):168\u2013177","journal-title":"J Clin Densitom"},{"issue":"5","key":"1020_CR48","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s00223-009-9225-y","volume":"84","author":"N Voorzanger-Rousselot","year":"2009","unstructured":"Voorzanger-Rousselot N et al (2009) Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases. Calcif Tissue Int 84(5):348\u2013354","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"1020_CR49","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00198-012-1978-x","volume":"24","author":"P Garnero","year":"2013","unstructured":"Garnero P et al (2013) Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int 24(2):489\u2013494","journal-title":"Osteoporos Int"},{"issue":"1","key":"1020_CR50","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/ndt\/gfr270","volume":"27","author":"D Cejka","year":"2012","unstructured":"Cejka D et al (2012) Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients. Nephrol Dial Transplant 27(1):226\u2013230","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1020_CR51","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12882-019-1452-5","volume":"20","author":"TH Kuo","year":"2019","unstructured":"Kuo TH et al (2019) Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study. BMC Nephrol 20(1):266","journal-title":"BMC Nephrol"},{"issue":"6","key":"1020_CR52","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1210\/jc.2011-3419","volume":"97","author":"A Arasu","year":"2012","unstructured":"Arasu A et al (2012) Serum sclerostin and risk of hip fracture in older Caucasian women. J Clin Endocrinol Metab 97(6):2027\u20132032","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1020_CR53","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1002\/jbmr.1718","volume":"27","author":"MS Ardawi","year":"2012","unstructured":"Ardawi MS et al (2012) High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study. J Bone Miner Res 27(12):2592\u20132602","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1020_CR54","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/jbmr.1823","volume":"28","author":"P Szulc","year":"2013","unstructured":"Szulc P et al (2013) Lower fracture risk in older men with higher sclerostin concentration: a prospective analysis from the MINOS study. J Bone Miner Res 28(4):855\u2013864","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1020_CR55","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s00223-016-0160-4","volume":"99","author":"Y Lim","year":"2016","unstructured":"Lim Y et al (2016) Decreased plasma levels of sclerostin but not Dickkopf-1 are associated with an increased prevalence of osteoporotic fracture and lower bone mineral density in postmenopausal korean women. Calcif Tissue Int 99(4):350\u2013359","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"1020_CR56","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00223-010-9334-7","volume":"86","author":"E Piters","year":"2010","unstructured":"Piters E et al (2010) Common genetic variation in the DKK1 gene is associated with hip axis length but not with bone mineral density and bone turnover markers in young adult men: results from the Odense Androgen Study. Calcif Tissue Int 86(4):271\u2013281","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"1020_CR57","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1210\/jc.2010-0067","volume":"95","author":"A Gaudio","year":"2010","unstructured":"Gaudio A et al (2010) Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab 95(5):2248\u20132253","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1020_CR58","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1530\/EJE-16-0652","volume":"176","author":"K Hygum","year":"2017","unstructured":"Hygum K et al (2017) Mechanisms in endocrinology: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. Eur J Endocrinol 176(3):R137\u2013R157","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"1020_CR59","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1002\/jbmr.4153","volume":"35","author":"A Piccoli","year":"2020","unstructured":"Piccoli A et al (2020) Sclerostin regulation, microarchitecture, and advanced glycation end-products in the bone of elderly women with Type 2 diabetes. J Bone Miner Res 35(12):2415\u20132422","journal-title":"J Bone Miner Res"},{"key":"1020_CR60","doi-asserted-by":"publisher","first-page":"115681","DOI":"10.1016\/j.bone.2020.115681","volume":"143","author":"JL Lauterlein","year":"2021","unstructured":"Lauterlein JL et al (2021) Serum sclerostin and glucose homeostasis: No association in healthy men. Cross-sectional and prospective data from the EGIR-RISC study. Bone 143:115681","journal-title":"Bone"},{"issue":"1","key":"1020_CR61","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1210\/jendso\/bvab183","volume":"6","author":"N Umekwe","year":"2022","unstructured":"Umekwe N et al (2022) Plasma FGF-21 and sclerostin levels, glycemia, adiposity, and insulin sensitivity in normoglycemic black and white adults. J Endocr Soc 6(1):183","journal-title":"J Endocr Soc"},{"key":"1020_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116159","volume":"153","author":"J Starup-Linde","year":"2021","unstructured":"Starup-Linde J et al (2021) Glucose variability and low bone turnover in people with type 2 diabetes. Bone 153:116159","journal-title":"Bone"},{"key":"1020_CR63","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.bone.2018.08.007","volume":"120","author":"A Wedrychowicz","year":"2019","unstructured":"Wedrychowicz A, Sztefko K, Starzyk JB (2019) Sclerostin and its significance for children and adolescents with type 1 diabetes mellitus (T1D). Bone 120:387\u2013392","journal-title":"Bone"},{"key":"1020_CR64","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bone.2018.07.021","volume":"120","author":"A Wedrychowicz","year":"2019","unstructured":"Wedrychowicz A, Sztefko K, Starzyk JB (2019) Sclerostin and its association with insulin resistance in children and adolescents. Bone 120:232\u2013238","journal-title":"Bone"},{"issue":"5","key":"1020_CR65","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1515\/jpem-2022-0001","volume":"35","author":"S Kurban","year":"2022","unstructured":"Kurban S, Selver Eklioglu B, Selver MB (2022) Investigation of the relationship between serum sclerostin and dickkopf-1 protein levels with bone turnover in children and adolescents with type-1 diabetes mellitus. J Pediatr Endocrinol Metab 35(5):673\u2013679","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"1020_CR66","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1210\/jc.2016-2371","volume":"102","author":"MF Faienza","year":"2017","unstructured":"Faienza MF et al (2017) High sclerostin and dickkopf-1 (DKK-1) serum levels in children and adolescents with Type 1 diabetes mellitus. J Clin Endocrinol Metab 102(4):1174\u20131181","journal-title":"J Clin Endocrinol Metab"},{"key":"1020_CR67","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001000","author":"S Lattanzio","year":"2014","unstructured":"Lattanzio S et al (2014) Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.114.001000","journal-title":"J Am Heart Assoc"},{"key":"1020_CR68","first-page":"9295313","volume":"2017","author":"J Shi","year":"2017","unstructured":"Shi J et al (2017) Serum sclerostin levels in patients with ankylosing spondylitis and rheumatoid arthritis: a systematic review and meta-analysis. Biomed Res Int 2017:9295313","journal-title":"Biomed Res Int"},{"key":"1020_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.12","volume":"48","author":"L Zhang","year":"2016","unstructured":"Zhang L et al (2016) Serum DKK-1 level in the development of ankylosing spondylitis and rheumatic arthritis: a meta-analysis. Exp Mol Med 48:e228","journal-title":"Exp Mol Med"},{"issue":"6","key":"1020_CR70","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00198-011-1806-8","volume":"23","author":"MS Ardawi","year":"2012","unstructured":"Ardawi MS et al (2012) Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study. Osteoporos Int 23(6):1789\u20131797","journal-title":"Osteoporos Int"},{"issue":"5","key":"1020_CR71","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1530\/EJE-10-0699","volume":"163","author":"AH van Lierop","year":"2010","unstructured":"van Lierop AH et al (2010) Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls. Eur J Endocrinol 163(5):833\u2013837","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1020_CR72","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s00198-013-2268-y","volume":"24","author":"ZE Belaya","year":"2013","unstructured":"Belaya ZE et al (2013) Serum extracellular secreted antagonists of the canonical Wnt\/beta-catenin signaling pathway in patients with Cushing\u2019s syndrome. Osteoporos Int 24(8):2191\u20132199","journal-title":"Osteoporos Int"},{"issue":"10","key":"1020_CR73","doi-asserted-by":"publisher","first-page":"E1953","DOI":"10.1210\/jc.2012-2218","volume":"97","author":"AH van Lierop","year":"2012","unstructured":"van Lierop AH et al (2012) Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment. J Clin Endocrinol Metab 97(10):E1953\u2013E1957","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1020_CR74","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00223-012-9684-4","volume":"92","author":"K Brabnikova Maresova","year":"2013","unstructured":"Brabnikova Maresova K, Pavelka K, Stepan JJ (2013) Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes. Calcif Tissue Int 92(4):354\u2013361","journal-title":"Calcif Tissue Int"},{"issue":"20","key":"1020_CR75","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.2174\/092986711796391660","volume":"18","author":"F Coluzzi","year":"2011","unstructured":"Coluzzi F et al (2011) Bone metastatic disease: taking aim at new therapeutic targets. Curr Med Chem 18(20):3093\u20133115","journal-title":"Curr Med Chem"},{"issue":"19","key":"1020_CR76","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2106\/JBJS.M.01096","volume":"96","author":"JT Compton","year":"2014","unstructured":"Compton JT, Lee FY (2014) A review of osteocyte function and the emerging importance of sclerostin. J Bone Joint Surg Am 96(19):1659\u20131668","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"1020_CR77","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bone.2012.04.016","volume":"51","author":"MP Yavropoulou","year":"2012","unstructured":"Yavropoulou MP et al (2012) Serum sclerostin levels in Paget\u2019s disease and prostate cancer with bone metastases with a wide range of bone turnover. Bone 51(1):153\u2013157","journal-title":"Bone"},{"key":"1020_CR78","doi-asserted-by":"publisher","first-page":"33551","DOI":"10.1038\/srep33551","volume":"6","author":"C Wibmer","year":"2016","unstructured":"Wibmer C et al (2016) Serum sclerostin levels in renal cell carcinoma patients with bone metastases. Sci Rep 6:33551","journal-title":"Sci Rep"},{"key":"1020_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105773","volume":"204","author":"RI El-Mahdy","year":"2020","unstructured":"El-Mahdy RI et al (2020) Circulating osteocyte-related biomarkers (vitamin D, sclerostin, dickkopf-1), hepcidin, and oxidative stress markers in early breast cancer: Their impact in disease progression and outcome. J Steroid Biochem Mol Biol 204:105773","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"1020_CR80","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/JLB.1AB0120-212RR","volume":"108","author":"E Galliera","year":"2020","unstructured":"Galliera E et al (2020) Longitudinal evaluation of Wnt inhibitors and comparison with others serum osteoimmunological biomarkers in osteolytic bone metastasis. J Leukoc Biol 108(2):697\u2013704","journal-title":"J Leukoc Biol"},{"key":"1020_CR81","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.metabol.2017.11.012","volume":"80","author":"E Terpos","year":"2018","unstructured":"Terpos E, Christoulas D, Gavriatopoulou M (2018) Biology and treatment of myeloma related bone disease. Metabolism 80:80\u201390","journal-title":"Metabolism"},{"issue":"6","key":"1020_CR82","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1600-0609.2008.01065.x","volume":"80","author":"M Kaiser","year":"2008","unstructured":"Kaiser M et al (2008) Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma. Eur J Haematol 80(6):490\u2013494","journal-title":"Eur J Haematol"},{"issue":"1","key":"1020_CR83","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1600-0609.2008.01164.x","volume":"82","author":"U Heider","year":"2009","unstructured":"Heider U et al (2009) Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment. Eur J Haematol 82(1):31\u201338","journal-title":"Eur J Haematol"},{"key":"1020_CR84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1749-6632.2011.06196.x","volume":"1237","author":"G Brunetti","year":"2011","unstructured":"Brunetti G et al (2011) Sclerostin is overexpressed by plasma cells from multiple myeloma patients. Ann N Y Acad Sci 1237:19\u201323","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1020_CR85","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1359\/jbmr.081104","volume":"24","author":"DJ Heath","year":"2009","unstructured":"Heath DJ et al (2009) Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma. J Bone Miner Res 24(3):425\u2013436","journal-title":"J Bone Miner Res"},{"issue":"26","key":"1020_CR86","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa030847","volume":"349","author":"E Tian","year":"2003","unstructured":"Tian E et al (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349(26):2483\u20132494","journal-title":"N Engl J Med"},{"issue":"5","key":"1020_CR87","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1600-0609.2012.01751.x","volume":"88","author":"M Laroche","year":"2012","unstructured":"Laroche M et al (2012) Dual-energy X-ray absorptiometry and biochemical markers of bone turnover after autologous stem cell transplantation in myeloma. Eur J Haematol 88(5):388\u2013395","journal-title":"Eur J Haematol"},{"issue":"7","key":"1020_CR88","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1002\/ijc.22033","volume":"119","author":"MC Politou","year":"2006","unstructured":"Politou MC et al (2006) Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation. Int J Cancer 119(7):1728\u20131731","journal-title":"Int J Cancer"},{"key":"1020_CR89","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bone.2017.10.004","volume":"113","author":"C Mabille","year":"2018","unstructured":"Mabille C et al (2018) DKK1 and sclerostin are early markers of relapse in multiple myeloma. Bone 113:114\u2013117","journal-title":"Bone"},{"issue":"3","key":"1020_CR90","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1600-0609.2009.01372.x","volume":"84","author":"O Lemaire","year":"2010","unstructured":"Lemaire O et al (2010) DKK1 correlates with response and predicts rapid relapse after autologous stem cell transplantation in multiple myeloma. Eur J Haematol 84(3):276\u2013277","journal-title":"Eur J Haematol"},{"issue":"2","key":"1020_CR91","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1161\/hs0202.103071","volume":"33","author":"R Vliegenthart","year":"2002","unstructured":"Vliegenthart R et al (2002) Stroke is associated with coronary calcification as detected by electron-beam CT: the rotterdam coronary calcification study. Stroke 33(2):462\u2013465","journal-title":"Stroke"},{"issue":"20","key":"1020_CR92","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1161\/01.CIR.0000068341.61180.55","volume":"107","author":"GT Kondos","year":"2003","unstructured":"Kondos GT et al (2003) Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 107(20):2571\u20132576","journal-title":"Circulation"},{"issue":"3","key":"1020_CR93","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000443845","volume":"132","author":"G Jean","year":"2016","unstructured":"Jean G et al (2016) High serum sclerostin levels are associated with a better outcome in haemodialysis patients. Nephron 132(3):181\u2013190","journal-title":"Nephron"},{"issue":"1","key":"1020_CR94","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/0886022X.2020.1741386","volume":"42","author":"Y Zou","year":"2020","unstructured":"Zou Y et al (2020) Association of sclerostin with cardiovascular events and mortality in dialysis patients. Ren Fail 42(1):282\u2013288","journal-title":"Ren Fail"},{"issue":"10","key":"1020_CR95","doi-asserted-by":"publisher","first-page":"E1854","DOI":"10.1210\/jc.2014-2042","volume":"99","author":"M Kanbay","year":"2014","unstructured":"Kanbay M et al (2014) Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients. J Clin Endocrinol Metab 99(10):E1854\u2013E1861","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1020_CR96","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/ndt\/gfu301","volume":"30","author":"C Drechsler","year":"2015","unstructured":"Drechsler C et al (2015) High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant 30(2):288\u2013293","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1020_CR97","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.2337\/dc12-1691","volume":"36","author":"S Morales-Santana","year":"2013","unstructured":"Morales-Santana S et al (2013) Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels. Diabetes Care 36(6):1667\u20131674","journal-title":"Diabetes Care"},{"issue":"1","key":"1020_CR98","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12882-018-1046-7","volume":"19","author":"A Chen","year":"2018","unstructured":"Chen A et al (2018) Associations of sclerostin with carotid artery atherosclerosis and all-cause mortality in Chinese patients undergoing maintenance hemodialysis. BMC Nephrol 19(1):264","journal-title":"BMC Nephrol"},{"issue":"1","key":"1020_CR99","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1479164113510923","volume":"11","author":"A Gaudio","year":"2014","unstructured":"Gaudio A et al (2014) The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus. Diab Vasc Dis Res 11(1):48\u201352","journal-title":"Diab Vasc Dis Res"},{"issue":"1","key":"1020_CR100","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bone.2013.05.010","volume":"56","author":"G Hampson","year":"2013","unstructured":"Hampson G et al (2013) The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women. Bone 56(1):42\u201347","journal-title":"Bone"},{"issue":"8","key":"1020_CR101","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00198-015-3127-9","volume":"26","author":"S Pelletier","year":"2015","unstructured":"Pelletier S et al (2015) Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients? Osteoporos Int 26(8):2165\u20132174","journal-title":"Osteoporos Int"},{"issue":"12","key":"1020_CR102","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1210\/jc.2014-2327","volume":"99","author":"J Paccou","year":"2014","unstructured":"Paccou J et al (2014) The relationships between serum sclerostin, bone mineral density, and vascular calcification in rheumatoid arthritis. J Clin Endocrinol Metab 99(12):4740\u20134748","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1020_CR103","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s11255-016-1387-8","volume":"48","author":"M Kanbay","year":"2016","unstructured":"Kanbay M et al (2016) Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis. Int Urol Nephrol 48(12):2029\u20132042","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"1020_CR104","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M et al (2017) Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what\u2019s changed and why it matters. Kidney Int 92(1):26\u201336","journal-title":"Kidney Int"},{"issue":"5","key":"1020_CR105","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2215\/CJN.07670712","volume":"8","author":"S Pelletier","year":"2013","unstructured":"Pelletier S et al (2013) The relation between renal function and serum sclerostin in adult patients with CKD. Clin J Am Soc Nephrol 8(5):819\u2013823","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"1020_CR106","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ki.2015.156","volume":"88","author":"P Evenepoel","year":"2015","unstructured":"Evenepoel P, D\u2019Haese P, Brandenburg V (2015) Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney Int 88(2):235\u2013240","journal-title":"Kidney Int"},{"issue":"3","key":"1020_CR107","doi-asserted-by":"publisher","first-page":"e980","DOI":"10.1210\/clinem\/dgab788","volume":"107","author":"NR Jorgensen","year":"2022","unstructured":"Jorgensen NR et al (2022) Patients with cirrhosis have elevated bone turnover but normal hepatic production of osteoprotegerin. J Clin Endocrinol Metab 107(3):e980\u2013e995","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1020_CR108","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1210\/jc.2013-2113","volume":"98","author":"C Durosier","year":"2013","unstructured":"Durosier C et al (2013) Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women. J Clin Endocrinol Metab 98(9):3873\u20133883","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1020_CR109","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1210\/jc.2014-2372","volume":"99","author":"E Ishimura","year":"2014","unstructured":"Ishimura E et al (2014) Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients. J Clin Endocrinol Metab 99(11):4315\u20134320","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1020_CR110","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1093\/ndt\/gft039","volume":"28","author":"L Viaene","year":"2013","unstructured":"Viaene L et al (2013) Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis? Nephrol Dial Transplant 28(12):3024\u20133030","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"1020_CR111","doi-asserted-by":"publisher","first-page":"222","DOI":"10.5414\/CN109650","volume":"91","author":"F Lima","year":"2019","unstructured":"Lima F et al (2019) Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers. Clin Nephrol 91(4):222\u2013230","journal-title":"Clin Nephrol"},{"issue":"4","key":"1020_CR112","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2215\/CJN.06550810","volume":"6","author":"D Cejka","year":"2011","unstructured":"Cejka D et al (2011) Sclerostin and Dickkopf-1 in renal osteodystrophy. Clin J Am Soc Nephrol 6(4):877\u2013882","journal-title":"Clin J Am Soc Nephrol"},{"issue":"15","key":"1020_CR113","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1073\/pnas.1221255110","volume":"110","author":"ZC Ryan","year":"2013","unstructured":"Ryan ZC et al (2013) Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium. Proc Natl Acad Sci USA 110(15):6199\u20136204","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1020_CR114","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/ki.2014.372","volume":"87","author":"RA de Oliveira","year":"2015","unstructured":"de Oliveira RA et al (2015) Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease. Kidney Int 87(5):1039\u20131045","journal-title":"Kidney Int"},{"issue":"6","key":"1020_CR115","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","volume":"95","author":"P Evenepoel","year":"2019","unstructured":"Evenepoel P et al (2019) Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients. Kidney Int 95(6):1461\u20131470","journal-title":"Kidney Int"},{"issue":"7","key":"1020_CR116","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2215\/CJN.09470913","volume":"9","author":"HH Malluche","year":"2014","unstructured":"Malluche HH et al (2014) Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis. Clin J Am Soc Nephrol 9(7):1254\u20131262","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"1020_CR117","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s11255-015-0971-7","volume":"47","author":"RM Moyses","year":"2015","unstructured":"Moyses RM et al (2015) Can we compare serum sclerostin results obtained with different assays in hemodialysis patients? Int Urol Nephrol 47(5):847\u2013850","journal-title":"Int Urol Nephrol"},{"issue":"8","key":"1020_CR118","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1093\/ndt\/gfz078","volume":"34","author":"K Hamada-Ode","year":"2019","unstructured":"Hamada-Ode K et al (2019) Serum dickkopf-related protein 1 and sclerostin may predict the progression of chronic kidney disease in Japanese patients. Nephrol Dial Transplant 34(8):1426\u20131427","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"1020_CR119","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/ndt\/gfv081","volume":"30","author":"M Morena","year":"2015","unstructured":"Morena M et al (2015) Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications. Nephrol Dial Transplant 30(8):1345\u20131356","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1020_CR120","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00223-012-9595-4","volume":"90","author":"S Thambiah","year":"2012","unstructured":"Thambiah S et al (2012) Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness. Calcif Tissue Int 90(6):473\u2013480","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1020_CR121","doi-asserted-by":"publisher","first-page":"E60","DOI":"10.1210\/jc.2012-3038","volume":"98","author":"TC Register","year":"2013","unstructured":"Register TC et al (2013) Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes. J Clin Endocrinol Metab 98(1):E60\u2013E65","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1020_CR122","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1210\/jc.2013-3201","volume":"99","author":"P Szulc","year":"2014","unstructured":"Szulc P et al (2014) Severe abdominal aortic calcification in older men is negatively associated with DKK1 serum levels: the STRAMBO study. J Clin Endocrinol Metab 99(2):617\u2013624","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1020_CR123","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1159\/000511658","volume":"51","author":"CM Forster","year":"2020","unstructured":"Forster CM et al (2020) Circulating levels of dickkopf-related protein 1 decrease as measured GFR declines and are associated with PTH levels. Am J Nephrol 51(11):871\u2013880","journal-title":"Am J Nephrol"},{"issue":"1","key":"1020_CR124","doi-asserted-by":"publisher","DOI":"10.15190\/d.2016.2","volume":"4","author":"SF Mause","year":"2016","unstructured":"Mause SF et al (2016) Validation of commercially available ELISAs for the detection of circulating sclerostin in hemodialysis patients. Discoveries (Craiova) 4(1):e55","journal-title":"Discoveries (Craiova)"},{"issue":"11","key":"1020_CR125","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1007\/s00198-017-4162-5","volume":"28","author":"C Swanson","year":"2017","unstructured":"Swanson C et al (2017) 24-hour profile of serum sclerostin and its association with bone biomarkers in men. Osteoporos Int 28(11):3205\u20133213","journal-title":"Osteoporos Int"},{"key":"1020_CR126","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bone.2018.10.002","volume":"120","author":"E van der Spoel","year":"2019","unstructured":"van der Spoel E et al (2019) The 24-hour serum profiles of bone markers in healthy older men and women. Bone 120:61\u201369","journal-title":"Bone"},{"issue":"3","key":"1020_CR127","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1530\/EJE-19-0309","volume":"181","author":"K Hygum","year":"2019","unstructured":"Hygum K et al (2019) The diurnal variation of bone formation is attenuated in adult patients with type 2 diabetes. Eur J Endocrinol 181(3):221\u2013231","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1020_CR128","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.kint.2019.06.007","volume":"96","author":"M Araujo","year":"2019","unstructured":"Araujo M et al (2019) Comparison of serum levels with bone content and gene expression indicate a contradictory effect of kidney transplantation on sclerostin. Kidney Int 96(5):1100\u20131104","journal-title":"Kidney Int"},{"issue":"2","key":"1020_CR129","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1365-2141.2009.07587.x","volume":"145","author":"N Voorzanger-Rousselot","year":"2009","unstructured":"Voorzanger-Rousselot N et al (2009) Platelet is a major contributor to circulating levels of Dickkopf-1: clinical implications in patients with multiple myeloma. Br J Haematol 145(2):264\u2013266","journal-title":"Br J Haematol"},{"issue":"12","key":"1020_CR130","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1002\/jbmr.474","volume":"26","author":"AH van Lierop","year":"2011","unstructured":"van Lierop AH et al (2011) Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover. J Bone Miner Res 26(12):2804\u20132811","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-022-01020-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-022-01020-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-022-01020-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T19:49:57Z","timestamp":1674244197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-022-01020-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":130,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["1020"],"URL":"https:\/\/doi.org\/10.1007\/s00223-022-01020-9","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"assertion":[{"value":"18 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Aylin Sepinci Dincel and Niklas Rye J\u00f8rgensen declare that they have no conflict of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No permissions for human or animal experiments have been sought and no informed consents from patients have\nbeen obtained as this is irrelevant as the current study is a review of existing literature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}]}}